PHASE-I TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR (RTNF) IN PATIENTS WITH ADVANCED MALIGNANCY

被引：0
|
作者：
KRIGEL, R
COMIS, R
PADAVIC, K
RUDOLPH, A
机构：
[1] FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
[2] CETUS CORP,EMERYVILLE,CA 94608
来源：
CLINICAL RESEARCH | 1987年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A806 / A806
页数：1
相关论文
共 50 条
  • [31] PHASE-I TRIAL OF INTRAVENOUS CONTINUOUS INFUSION OF TUMOR NECROSIS FACTOR IN ADVANCED METASTATIC CARCINOMAS
    WIEDENMANN, B
    REICHARDT, P
    RATH, U
    THEILMANN, L
    SCHULE, B
    HO, AD
    SCHLICK, E
    KEMPENI, J
    HUNSTEIN, W
    KOMMERELL, B
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (02) : 189 - 192
  • [32] A PHASE-I TRIAL OF INTRAVENOUSLY-ADMINISTERED RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA IN CANCER-PATIENTS
    FEINBERG, B
    KURZROCK, R
    TALPAZ, M
    BLICK, M
    SAKS, S
    GUTTERMAN, JU
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) : 1328 - 1334
  • [33] PHASE-I STUDY OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR IN CANCER-PATIENTS
    SHERMAN, ML
    SPRIGGS, DR
    DEMETRI, GD
    ARTHUR, K
    IMAMURA, K
    KUFE, DW
    FREI, E
    [J]. IMMUNOBIOLOGY, 1987, 175 (1-2) : 33 - 33
  • [34] PHASE-I STUDIES OF RTNF-ALPHA IN PATIENTS WITH ADVANCED CANCER
    GABRILOVE, JL
    STARNES, HF
    BEGAS, A
    CASPER, E
    CHAPMAN, P
    ENGERT, A
    JAKUBOWSKI, A
    TEMPLETON, MA
    SHERWIN, S
    BRENNAN, M
    OETTGEN, HF
    [J]. IMMUNOBIOLOGY, 1987, 175 (1-2) : 12 - 13
  • [35] A PHASE-I PHARMACOKINETIC STUDY OF RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR ADMINISTERED BY A 5-DAY CONTINUOUS INFUSION
    MITTELMAN, A
    PUCCIO, C
    GAFNEY, E
    COOMBE, N
    SINGH, B
    WOOD, D
    NADLER, P
    AHMED, T
    ARLIN, Z
    [J]. INVESTIGATIONAL NEW DRUGS, 1992, 10 (03) : 183 - 190
  • [36] RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR CAUSES REGRESSION IN PATIENTS WITH ADVANCED MALIGNANCIES
    WATANABE, N
    YAMAUCHI, N
    MAEDA, M
    NEDA, H
    TSUJI, Y
    OKAMOTO, T
    TSUJI, N
    AKIYAMA, S
    SASAKI, H
    NIITSU, Y
    [J]. ONCOLOGY, 1994, 51 (04) : 360 - 365
  • [37] RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR ALPHA (RHTNF-ALPHA) IN ADVANCED CANCER - A PHASE-I CLINICAL-TRIAL
    MERTELSMANN, R
    GAMM, H
    FLENER, R
    HERRMANN, F
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 399 - 399
  • [38] PHASE-I STUDY OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR-ALPHA IN ADVANCED MALIGNANT DISEASE
    MORITZ, T
    NIEDERLE, N
    BAUMANN, J
    MAY, D
    KURSCHEL, E
    OSIEKA, R
    KEMPENI, J
    SCHLICK, E
    SCHMIDT, CG
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 29 (02) : 144 - 150
  • [39] PHASE-I CLINICAL-TRIAL OF RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR IN CHILDREN WITH REFRACTORY SOLID TUMORS - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    FURMAN, WL
    STROTHER, D
    MCCLAIN, K
    BELL, B
    LEVENTHAL, B
    PRATT, CB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (11) : 2205 - 2210
  • [40] A PHASE-I TRIAL OF RECOMBINANT HUMAN GAMMA INTERFERON (IFN-GAMMA-4A) IN PATIENTS WITH ADVANCED MALIGNANCY
    PEREZ, R
    LIPTON, A
    HARVEY, HA
    SIMMONDS, MA
    ROMANO, PJ
    IMBODEN, SL
    GIUDICE, G
    DOWNING, MR
    ALTON, NK
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1988, 7 (03): : 309 - 317
12345